Business

Analysts Optimistic about Healthcare Stocks: Aerie Pharma (AERI), Tenax Therapeutics (TENX)

By Tanvi Sabharwal

There’s a lot of talk about stocks in the Healthcare sector leaving analysts hopeful as they weigh in on Aerie Pharma (AERI) and Tenax Therapeutics (TENX).

In a report, Serge Belanger, a 4-star analyst from Needham assigned a Buy rating to Aerie Pharma, with a price target of $26.00. The company’s shares closed last Friday at $18.55.

Belanger has an average return of 8.5% and a 48.2% success rate and covers the Healthcare sector. He focuses on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals.

In another report, Vernon Bernardino of H.C. Wainwright reiterated a Buy rating on Tenax Therapeutics, with a price target of $5.00. The company’s shares closed last Friday at $2.19.

Bernardino, a 5-star analyst with an average return of 32.6% and a 41.1% success rate, covers the Healthcare sector, with a focus on stocks such as Citius Pharmaceuticals, Aridis Pharmaceuticals, and Achieve Life Sciences.

Tenax Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $5.00.

Tags: healthcare stocks

Tanvi Sabharwal

Tanvi Sabharwal is a graduate in Economics with experience in marketing and strategy. A media enthusiast, she has a deep-rooted interest in social policy and development. Tanvi is currently working as a Business and Current Affairs reporter at USAnewshour.com and can be reached at tanvi.sabharwal21@gmail.com